Streetbeat News

Stock Prices

DCTH

Delcath Systems announced that the FDA has approved its HEPZATO KIT for the treatment of adult patients with unresectable hepatic-dominant metastatic uveal melanoma. Following the announcement, the company's shares surged by 69% in premarket trading.

Portfolio Pulse from Charles Gross

August 15, 2023 | 11:12 am

NAPA

B of A Securities analyst Peter Galbo maintains a Buy rating on Duckhorn Portfolio (NYSE:NAPA) but lowers the price target from $20 to $18.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 11:07 am

CALT

DFS

DSGN

FRHC

GETY

GOL

HRYU

HTH

VNO

Several US-listed stocks traded lower in Tuesday's pre-market session. Design Therapeutics fell 37.9% after reporting Q2 results and initial results from a Phase 1 study. Getty Images declined 18.6% after reporting Q2 earnings. Freedom Holding fell 12.8% after receiving a Nasdaq noncompliance notification. Sea Limited fell 11.7% following weaker-than-expected quarterly results. Calliditas Therapeutics fell 7.8% after announcing full results from a Phase 3 trial. Kanzhun, Hanryu Holdings, Discover Financial Services, Hilltop Holdings, Vornado Realty Trust, and Gol Linhas Aéreas Inteligentes also recorded losses.

Portfolio Pulse from Lisa Levin

August 15, 2023 | 11:00 am

PSFE

Paysafe Limited has updated its FY23 revenue forecast to $1.595B-$1.608B, up from the previous estimate of $1.580B-$1.600B. This is slightly above the estimated $1.59B.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:59 am

CAH

Cardinal Health has increased its FY24 adjusted EPS guidance to $6.50-$6.75, up from the previous guidance of $6.45-$6.70. The new guidance is above the consensus estimate of $6.59.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:59 am

RSKD

Riskified Ltd. (NYSE:RSKD) has authorized the repurchase of up to $75M of the company's ordinary shares, subject to approval by the Tel Aviv District Court Economic Department. The repurchases are expected to be used to manage share dilution and to take advantage of attractive repurchase opportunities.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:57 am

WATT

Energous (NASDAQ:WATT) reported Q2 adjusted losses of $(0.06) per share, beating the analyst consensus estimate of $(0.07) by 14.29%. However, the company's quarterly sales of $117.13K missed the analyst consensus estimate of $220.00K by 46.76%, marking a 49.72% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:56 am

NVDA

Nvidia Corp. (NASDAQ:NVDA) shares were higher in premarket trading following a 7% rally on Monday. The positive sentiment reflects optimism over the uptake of its high-performance chips for AI software and applications. Morgan Stanley analyst Joseph Moore issued an upbeat commentary on the company’s second-quarter results due on Aug. 23 and also the near-term outlook. Daniel Loeb’s Third Point took a new position in Nvidia in the second quarter.

Portfolio Pulse from Shanthi Rexaline

August 15, 2023 | 10:48 am

INFY

LBTYA

Liberty Global PLC (LBTYA) has expanded its collaboration with Infosys Ltd (INFY) to enhance its digital entertainment and connectivity platforms and ensure cost efficiency. The initial 5-year deal could extend to 8 years and beyond, with Infosys offering services worth €1.5 billion over the initial period and €2.3 billion if extended. Liberty Global expects to realize annual savings of over €100 million. The partnership will enable new customers to experience advanced digital services and create career opportunities for over 400 Liberty Global employees.

Portfolio Pulse from Lekha Gupta

August 15, 2023 | 10:39 am

TFFP

TFF Pharmaceuticals has priced its underwritten public offering of 19.8 million shares at $0.25 per share, with gross proceeds expected to be approximately $4.97 million.

Portfolio Pulse from Benzinga Newsdesk

August 15, 2023 | 10:31 am